Aurobindo Pharma Ltd
NSE: AUROPHARMA BSE: 524804
₹1705
+10.50 (0.62%)
Fri, 06 Nov 2026, 10:01 pm
Market Cap (in Cr)97756.7
PE Ratio26.64
Dividend0.24
Health Technology
Pharmaceuticals: Other
24.5KAurobindo Pharma Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| GOLDMAN SACHS BANK EUROPESE - ODI | block | Buy | 106228 | 1107 | 16 Oct 2025 |
| GOLDMAN SACHS (SINGAPORE) PTE.- ODI | block | Sell | 106228 | 1107 | 16 Oct 2025 |
| MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | block | Buy | 27571 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES - SYSTEMATIC ALPHA PLUS FUND | block | Buy | 15950 | 1160.1 | 25 Jan 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 150001 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES SYSTEMATIC ALPHA PLUS FUND | block | Buy | 862 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES - EUREKA FUND | block | Buy | 106480 | 1160.1 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Buy | 1484323 | 1160.1 | 25 Jan 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 1484323 | 1160.1 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIES EUREKA FUND | block | Buy | 53641 | 1160.1 | 25 Jan 2024 |
Showing 1–10 of 92
Rows per page:
